September 3, 2026 Sophia Vida
Breaking News

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

POMPANO BEACH, Fla., Sept. 03, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) –BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment … Continue reading “BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference”